Jina Pharmaceuticals, Inc.   Report issue

For profit Phase 3
Founded: Libertyville IL United States (2006)
Status: No NME R&D (2006)

Organization Overview

First Clinical Trial
2013
NCT01957995
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Jina Pharmaceuticals Inc.

Active Ingredients

Drugs in Phase 3 Trials (2)

docetaxel (taxotere) (2 trials)

endoxifen (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 3)

Disease (Phase 3)

Neoplasms (Phase 1)

Triple Negative Breast Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 2